β¨ Medicines Act Notices
28 JULY 2011
NEW ZEALAND GAZETTE, No. 113
3201
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Cefazolin-AFT
Active Ingredient: Cefazolin sodium 1.08g equivalent to cefazolin 1g
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Qilu Pharmaceutical Co Limited, Shandong Province, China
Product: Cefazolin-AFT
Active Ingredient: Cefazolin sodium 540mg equivalent to Cefazolin 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Qilu Pharmaceutical Co Limited, Shandong Province, China
Product: Imodium Zapid
Active Ingredient: Loperamide hydrochloride 2mg
Dosage Form: Orodispersible tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Catalent UK Swindon Zydis Limited, Wiltshire, United Kingdom
Dated this 22nd day of July 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5101
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Advil Infantβs Pain & Fever Relief
Active Ingredient: Ibuprofen 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Interphil Laboratories Inc, Laguna, Philippines
Product: Dimetapp PE Sinus Day + Night
Day Tablet
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
Night Tablet
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Dimetapp PE Sinus Pain
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare22 July 2011
Medicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
NZ Gazette 2011, No 113